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PURPOSE. The role of adrenergic innervation in the regulation of lacrimal gland (LG) ductal
fluid secretion is unknown. The Aim of the present study was to investigate the effect of
adrenergic stimulation on fluid secretion in isolated LG duct segments and to study the
underlying intracellular mechanisms.
METHODS. Fluid secretion of isolated mouse LG ducts was measured using video-
microscopy. Effect of various adrenergic agonists (norepinephrine, phenylephrine, and
isoproterenol) on fluid secretion as well as inhibitory effects of specific antagonists on
adrenergic agonist-stimulated secretory response were analyzed. Changes in intracellular
Ca2+ level [Ca2+i] were investigated with microfluorometry.
RESULTS. Both norepinephrine and phenylephrine initiated a rapid and robust fluid secre-
tory response, whereas isoproterenol did not cause any secretion. Phenylephrine-induced
secretion was completely blocked by α1D-adrenergic receptor blocker BMY-7378. The
endothelial nitric oxide synthase (eNOS) inhibitor L-NAME or guanylyl cyclase inhibitor
ODQ reduced but not completely abolished the phenylephrine-induced fluid secretion,
whereas co-administration of Ca2+-chelator BAPTA-AM resulted in a complete blockade.
Phenylephrine stimulation induced a small, but statistically significant elevation in [Ca2+i ].
CONCLUSIONS. Our results prove the direct role of α1-adrenergic stimulation on LG ductal
fluid secretion. Lack of isoproterenol-induced fluid secretory response suggests the
absence of β-receptor mediated pathway in mouse LG ducts. Complete blockade of
phenylephrine-induced fluid secretion by BMY-7378 and predominant inhibition of the
secretory response either by L-NAME or ODQ suggest that α-adrenergic agonists use the
NO/cGMP pathway through α1D receptor. Ca2+ signaling independent from NO/cGMP
pathway may also play an at least partial role in α-adrenergic induced ductal fluid secre-
tion.
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Tear film is a substantial protector of the ocular surface. Apredominant amount of the aqueous layer is produced
by the lacrimal gland (LG).1 Similar to other exocrine glands,
LG consists of acini and ducts.2 Most of the research activi-
ties were focusing on the function of acinar cells and much
less efforts have been paid to the investigation of the ductal
system, even though an important role of the duct cells in
LG function has been assumed for a long time.3,4 Lack of
experimental methods suitable to examine the function of
LG ducts hindered the availability of studies focusing solely
on the role of the duct system. An isolated duct model was
developed in our laboratory with the modification of the
method used in pancreas duct research.5,6 Using this model
and a video-microscopy technique, experimental evidence of
fluid secretion of rabbit LG ducts was given, confirming the
important role of ducts in tear secretion.7 The isolated duct
model is also suitable for the investigation of the regulatory
mechanisms of the duct system.5,7–9
Autonomic regulation of the ductal function is not fully
explored. Parasympathetic pathways are the main regulatory
system of the LG, whereas sympathetic effects have been
supposed to play indirect role through blood flow regula-
tion.10–12 There is increasing evidence, however, that sympa-
thetic stimulation - apart from the hemodynamic effects -
plays a direct and important role in the protein secretion
of the LG.13,14 Although earlier reports suggested that both
α1 and β1-adrenergic agonists could result in protein secre-
tory response in whole LG pieces of mouse and rat, the
role of α1-adrenergic receptors is expected to be more rele-
vant.15,16 Furthermore, intracellular mechanisms mediating
α-adrenergic stimulation in LGs involve additional pathways
beside the conventional route through activation of phos-
pholipase C.17 This conception is supported by the well
documented fact that the dominant α-adrenergic receptor
subtype presents in the LG is the α1D and not the most
common α1A or α1B subtypes.18,19 Intracellular mechanisms
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TABLE. Composition of Solution
Content of Solutions







Dulbecco’s Modified Eagle Medium X X
Collagenase, U/mL 100
Bovine serum albumin, mg/mL 1 0.03
McCoy’s 5A Tissue Culture Medium X
Fetal calf serum, vol/vol % 10
Glutamine, mM 2
of α1D-adrenergic receptor activation are not clearly under-
stood. Additionally, involvement of the NO/cGMP pathway
was suggested in the phenylephrine-induced protein secre-
tion of rat LG.18 All these results were obtained from studies
investigating the effect of adrenergic stimulation on acinar
cells or on whole LG pieces. However, the effect of adren-
ergic stimulation as well as the intracellular mechanisms
underlying this process in ducts of LGs are completely
unknown.
Therefore, the aim of the present study was to investi-
gate the effect of adrenergic stimulation on fluid secretion
of isolated LG duct segments and to study the intracellular
mechanisms underlying adrenergic stimulation.
Parts of the results in this paper have been presented
in abstracts in the Annual Meetings of the Association for
Research in Vision and Ophthalmology (Berczeli O., et al.




Mouse exorbital LGs dissected from 12 to 16 week old wild
type FVB/N mice (a total of 56 animals) were used through-
out the study. Animals were narcotized intraperitoneally
with ketamine (80 mg/kg) and xylazine (10 mg/kg), and
euthanized with pentobarbital overdose (100 mg/kg).
All experiments were conducted in compliance with the
ARVO Statement for the Use of Animals in Ophthalmic and
Vision Research. The protocol was approved by the Ethical
Committee for the Protection of Animals in Research of the
University of Szeged, Szeged, Hungary, and conformed to
the Directive 2010/63/EU of the European Parliament.
Solutions and Chemicals
Media and its supplements for LG duct isolation and culture
(Dulbecco’s modified Eagle medium, McCoy’s 5A tissue
culture medium, fetal calf serum, glutamine, and bovine
serum albumin), phenylephrine, isoprenaline, propra-
nolol, phentolamine, norepinephrine, carbachol (carbamyl-
choline chloride), endothelial nitric oxide synthase (eNOS)
inhibitor L-NAME, guanylyl cyclase inhibitor ODQ, and α1D-
adrenergic receptor inhibitor BMY-7378 were purchased
from Sigma-Aldrich Corp. (Budapest, Hungary). Collagenase
was purchased from Worthington Biochemical Corp. (Lake-
wood, NJ, USA). FURA2-AM was purchased from Invitrogen
(Waltham, MA, USA). The compositions of solutions used in
our experiments are summarized in the Table. The standard
HCO3−/CO2− buffered solution was gassed with 95% O2/5%
CO2 at 37°C.
Isolation of Ducts From Mouse LGs
Mouse LG interlobular ducts were isolated as previously
described by our laboratory.5 Briefly, LGs were dissected
and transferred to a sterile small flat-bottom glass flask
containing cold (4°C) storage solution. Isolation solution
was injected into the interstitium of the glands and the
tissue pieces were transferred to a glass flask containing
2 mL of isolation solution. Following a 15 minute incubation
period in a shaking water bath at 37°C, isolation solution was
removed and 5 mL of fresh cold storage (4°C) solution was
added to the flask. LG tissue samples were transferred to a
glass microscope slide and viewed under stereo-microscope.
Following the microdissection of the ducts, the isolated duct
segments were transferred to the culture solution in a Petri
dish. Isolated ducts were cultured overnight in a 37°C incu-
bator gassed with 5% CO2.
Measurement of Ductal Fluid Secretion
Video-microscopic method was used for the measurement
of ductal fluid secretion. The technique was originally
described for the investigation of pancreatic ducts and was
adapted by our laboratory for the measurement of ductal
fluid secretion.6,7 In brief, ends of the isolated ducts seal
after 8 to 10 hours of incubation. Secretory processes of the
epithelial cells result in luminal volume (LV) increase of the
ducts as the closed luminal space fills with the secreted fluid.
The change in ductal volume can be analyzed with video-
microscopy. Scion Image (Scion Corporation, Frederick, MD,
USA) software was used to analyze and calculate changes in
the LV.
Measurement of Intracellular Ca2+
Ca2+-sensitive fluorescent dye FURA 2AM (5 μM) was
used for the measurement of intracellular Ca2+ concen-
tration [Ca2+]i as described earlier.5 Changes in [Ca2+]i
were measured using an imaging system (Xcellence; Olym-
pus, Budapest, Hungary). Four to 5 small areas (region of
interests [ROIs]) of 5 to 10 cells in each intact duct were
excited with light at 340 nm and 380 nm, and the 380 / 340
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FIGURE 1. Effect of different adrenergic agonists on ductal fluid secretion in isolated lacrimal gland ducts. Isolated lacrimal gland ducts
were stimulated with norepinephrine (10 μM), or with phenylephrine (10 μM) in the presence of propranolol (1 μM) or with isoproterenol
(200 μM) in the presence of phentolamine (10 μM). Secretory response of ducts was measured with video-microscopy. Changes in relative
luminal volume (Vr) are shown. Data were obtained at least from six ducts isolated from three different animals in each series and are
presented as means ± SEM.
fluorescence emission ratio were measured at 510 nm. One
[Ca2+]i measurement was obtained per second.
Statistical Analysis
For the analysis of ductal fluid secretion, effects of the
stimulatory agents (phenylephrine, isoproterenol, and nore-
pinephrine) were considered as “fixed effects.” The effect
of the individual “duct” and the “duct and effects of
phenylephrine/isoproterenol/ norepinephrine interaction”
(we presumed the individual duct-dependent effects of the
stimulatory compounds) were taken into account as random
effects. For the investigation of the inhibitory effect of L-
NAME, ODQ, and BMY-7378, data were expressed as the
percent change of the LV above baseline LV (baseline LV
was considered 1.0). A mixed ANOVA model was used for
statistics, by using SigmaPlot version 12.5 (Systat Software
Inc., San Jose, CA, USA), results were presented as means ±
SEM. A P value of < 0.05 was regarded as significant.
RESULTS
Effect of Adrenergic Agonists on Fluid Secretion
of LG Ducts
Isolated mouse LG ducts were used for the investigation of
the effect of various adrenergic agonist on ductal fluid secre-
tion. In the first series of experiments, ducts were stimulated
with various concentrations (5, 10, or 20 μM) of the natural
adrenergic agonist norepinephrine (noradrenaline) to deter-
mine the secretory response and dose-response relation-
ship. Norepinephrine stimulates both α- and β-adrenergic
receptors causing a complete adrenergic upset. Applica-
tion of norepinephrine initiated a dose-dependent, rapid
fluid secretory response (5 μM: 120.7 ± 19.1 pl/min/mm2;
10 μM: 189.6 ± 13.9 pl/min/mm2; and 20 μM: 181.5 ±
11.7 pl/min/mm2 in the first 10 minutes of stimulation). The
most effective concentration of norepinephrine proved to be
10 μM (Fig. 1), higher concentration (20 μM) did not result
in further increase in the secretory response of the investi-
gated ducts. To analyze the role of various adrenergic recep-
tors in the observed secretory response, effects of selective
α1 and β1-adrenergic stimulations were investigated. In the
α1-adrenergic studies, ducts were stimulated with phenyle-
phrine. Various concentrations (5, 10, or 20 μM) were used
to determine the secretory response and dose-response rela-
tionship. To ensure the blockade of β-adrenergic recep-
tors, phenylephrine was administered in the presence of
β-adrenergic antagonist propranolol (1 μM). Phenylephrine
stimulation caused a rapid fluid secretory response in the
isolated duct segments (Fig. 1). Supplementary Video S1
demonstrates the effect of phenylephrine stimulation on
ductal fluid secretion. The most effective concentration of
phenylephrine found to be 10 μM (secretory rates in the first
10 minutes of stimulation: 5 μM: 116.5 ± 19.1 pl/min/mm2;
10 μM:187.8 ± 26.8 pl/min/mm2; and 20 μM: 182.1 ±
22.5 pl/min/mm2). Therefore, concentration of 10 μM was
used throughout the additional phenylephrine experiments.
It is important to mention that no statistically significant
difference was detected between the extent of the fluid
secretory rates evoked by phenylephrine in the presence
of propranolol versus norepinephrine (P = 0.42) and the
kinetics of these stimulated secretions were also similar.
Effect of β-adrenergic stimulation on ductal fluid secre-
tion was also investigated. β-adrenergic agonist isopro-
terenol was administered in the presence of α-adrenergic
antagonist phentolamine (10 μM) to ensure the selective
β-adrenergic stimulation. Isoproterenol failed to elicit any
detectable secretory effect in all applied concentrations
(secretory rates in the first 10 minutes of stimulation: 50 μM:
−0.2 ± 11.4 pl/min/mm2; 100 μM: 0.1 ± 17.1 pl/min/mm2;
and 200 μM: −0.8 ± 19.7 pl/min/mm2). Figure 1 exhibits
secretory result of the highest isoproterenol concentration
applied (200 μM).
Effect of α1D-Adrenergic Receptor Antagonist
BMY-7378 on Phenylephrine-Evoked Ductal Fluid
Secretion
Secretory response of isolated ducts suggested to be clearly
due to the stimulation of α-adrenergic receptors in our
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FIGURE 2. Effect of BMY-7378 pretreatment on phenylephrine
induced secretory response of isolated lacrimal gland ducts. Isolated
ducts were stimulated with phenylephrine (10 μM) either in the
presence or in the absence of α1D-receptor antagonist BMY-7378
(100 μM). Secretory response of ducts was measured with video-
microscopy. Changes in relative luminal volume (LVr) are shown.
Data were obtained at least from six ducts isolated from three differ-
ent animals in each series and are presented as means ± SEM.
experiments. Earlier studies demonstrated that α-adrenergic
receptor subtype present in the acinar epithelial cells of LG
is the α1D.18,19 Therefore, we investigated the effect of α1D-
adrenergic blockade to explore the subtype of the involved
receptors in the isolated mouse LG ducts. Duct segments
were pre-incubated with different doses of selective α1D
receptor antagonist BMY-7378 (1, 10, 100, or 200 μM) for
30 minutes and then phenylephrine (10 μM) was added to
the superfusate. BMY-7378 reduced phenylephrine-induced
ductal fluid secretion in a dose-dependent manner (1 μM:
58.27 ± 7.12% above baseline LV; 10 μM: 42.24 ± 6.51%
above baseline LV; 100 μM: 7.64 ± 9.68% above baseline LV;
and 200 μM: 7.69 ± 8.71% above baseline LV; maximal inhi-
bition at 100 μM [baseline LV means unstimulated state]). The
difference between baseline LV and the LV measured follow-
ing phenylephrine stimulation in the presence of 100 μM
BMY-7378 was statistically not significant (P= 0.081). There-
fore, administration of 100 μM BMY-7378 completely abol-
ished phenylephrine-induced ductal fluid secretion proving
the role of α1D-adrenergic receptors in the observed secre-
tory response (Fig. 2).
Effect of eNOS Inhibitor L-NAME and Guanylyl
Cyclase Inhibitor ODQ on Phenylephrine-Induced
Ductal Fluid Secretion
Because the mechanisms underlying α1D-adrenergic recep-
tor stimulation involve the NO/cGMP pathway, the role of
this intracellular pathway was investigated in the next series
of experiments. LG ducts were pre-incubated with different
doses of eNOS inhibitor L-NAME (1, 10, 100, or 200 μM) for
30 minutes and then 10 μM of phenylephrine was added to
the bath. Phenylephrine-evoked ductal fluid secretion was
reduced by L-NAME in a dose-dependent manner (1 μM:
FIGURE 3. Effect of L-NAME and L-NAME/BAPTA-AM pretreatment
on phenylephrine induced secretory response of isolated lacrimal
gland ducts. Isolated ducts were stimulated with phenylephrine
(10 μM) either in the absence of eNOS inhibitor L-NAME or in the
presence of L-NAME (100 μM) alone or combined with Ca2+ chela-
tor BAPTA-AM (10 μM). Secretory response of ducts was measured
with video-microscopy. Changes in relative luminal volume (LVr)
are shown. Data were obtained at least from six ducts isolated from
three different animals in each series and are presented as means
± SEM.
53.01 ± 8.2% above baseline LV; 10 μM: 33.5 ± 10.02% above
baseline LV; 100 μM: 21.82 ± 13.52% above baseline LV;
and 200 μM: 22.14 ± 14.10% above baseline LV; maximal
inhibition at 100 μM). However, even at the maximal inhi-
bition effect of L-NAME, a significant difference (P = 0.023)
was found between baseline LV and LV measured follow-
ing phenylephrine stimulation in the presence of L-NAME
(Fig. 3). These results suggest that administration of L-NAME
reduced, but not completely abolished the phenylephrine-
induced fluid secretion of isolated LG ducts.
In the next series of experiments, LG ducts were pre-
incubated with different doses of guanylyl cyclase inhibitor
ODQ (0.1, 1, 10, or 100 μM) for 30 minutes before admin-
istration of phenylephrine (10 μM). Inhibition of guany-
lyl cyclase with ODQ decreased phenylephrine-induced LV
increase in a dose dependent manner (0.1 μM: 70.90 ± 9.07%
above baseline LV; 1 μM: 55.28 ± 10.01% above baseline LV;
10 μM: 21.78 ± 2.97% above baseline LV; and 100 μM: 23.12
± 5.20% above baseline LV). Maximal inhibition occurred at
10 μM ODQ concentration. Although the inhibitory effect
of ODQ was visible, a significant difference (P = 0.0008)
was proved between baseline LV and LV measured follow-
ing phenylephrine stimulation in the presence of ODQ
(Fig. 4). Effect of ODQ administration was similar to that
L-NAME produced in the previous experiments: it reduced,
but not completely inhibited phenylephrine-induced ductal
fluid secretion.
Phenylephrine-Evoked Ca2+ Signaling in Isolated
LG Duct Segments
Although α1D receptor blockage with BMY-7378 completely
abolished phenylephrine-induced ductal fluid secretion,
inhibition of eNOS or guanylyl cyclase considerably reduced
but could not block it completely. We hypothesized in the
background of this phenomenon that the elevation of [Ca2+]i
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FIGURE 4. Effect of ODQ and ODQ/BAPTA-AM pretreatment on
phenylephrine induced secretory response of isolated lacrimal
gland ducts. Isolated ducts were stimulated with phenylephrine (10
μM) either in the absence of guanylyl cyclase inhibitor ODQ or in
the presence of ODQ (10 μM) alone or combined with Ca2+ chela-
tor BAPTA-AM (10 μM). Secretory response of ducts was measured
with video-microscopy. Changes in relative luminal volume (LVr)
are shown. Data were obtained at least from six ducts isolated from
three different animals in each series and are presented as means
± SEM.
as a consequence of α1D-adrenergic receptor activation may
contribute to the fluid secretion of the ducts.
To investigate this theory, in the next series of
experiments, [Ca2+]i change was measured in response to
phenylephrine stimulation. In these experiments, applied
concentration of phenylephrine was 10 μM similarly to
the fluid secretion experiments. Stimulation of α-adrenergic
receptors by phenylephrine resulted in a small, but statisti-
cally significant increase in [Ca2+]i (P = 0.012). The extent
of this increase was much smaller (Fig. 5), compared to the
response we observed previously during carbachol stimula-
tion in epithelial cells of isolated mouse LG ducts.9
Effect of Ca2+ Chelator BAPTA-AM on
Phenylephrine-Induced Ductal Fluid Secretion
Phenylephrine-induced ductal fluid secretion was measured
in BAPTA-AM pretreated ducts in order to investigate the
role of Ca2+ in the secretory process. Phenylephrine stim-
ulation resulted in 169.21 ± 22.5 pl/min/mm2 fluid secre-
tory rate in duct cells preloaded with 10 μM of BAPTA-
AM. Although this value was slightly lower compared to
the secretory rate evoked by phenylephrine alone (187.8 ±
26.8 pl/min/mm2), no statistically significant difference
could be demonstrated in the fluid secretion between
BAPTA-AM-treated and non-treated ducts (P = 0.052).
Effect of Co-Administration of L-NAME or ODQ
With Ca2+ Chelator BAPTA-AM on
Phenylephrine-Induced Ductal Fluid Secretion
In contrast to BMY-7378, eNOS inhibitor L-NAME consider-
ably reduced but not completely abolished phenylephrine-
induced ductal fluid secretion. To investigate the poten-
tial role of phenylephrine-evoked elevation of [Ca2+]i, the
effect of L-NAME on phenylephrine-induced secretion was
investigated in the presence of intracellular Ca2+-chelator
BAPTA-AM. In these experiments, isolated ducts were
pre-incubated with the most effective dose of L-NAME
(100 μM) and BAPTA-AM (10 μM). Co-administration of
L-NAME and BAPTA-AM completely blocked phenylephrine-
induced ductal fluid secretion (LV change: 2.1 ± 4.8% above
baseline LV, P = 0.67).
Based on similar considerations (i.e. further investigation
of reduced but not completely abolished phenylephrine-
induced ductal fluid secretion in ODQ experiments)
phenylephrine-induced secretion was also studied in the
combined presence of ODQ and intracellular Ca2+-chelator
BAPTA-AM. Isolated ducts were pre-incubated with ODQ
(10 μM) and BAPTA-AM (10 μM) in these experiments.
A complete inhibition of phenylephrine-induced ductal
fluid secretion was observed following co-administration
of ODQ and BAPTA-AM: change of LV was negligible
and nonsignificant compared to baseline value (LV change:
3.1 ± 2.5% above baseline LV, P = 0.63).
DISCUSSION
Tear secretion is regulated by the autonomic nervous system.
Besides the generally accepted decisive role of parasym-
pathetic innervation, there is accumulating experimental
evidence about the direct effect of sympathetic regulation
of LG function.13–20 The presumptive role of adrenergic
regulation was confirmed in studies focusing on protein
secretion of acinar cells and whole LG pieces from rat
and mouse.15,16,20,21 In the present study, role of adrener-
gic effect in the regulation of LG ductal fluid secretion is
demonstrated. Application of the natural adrenergic trans-
mitter norepinephrine (or noradrenaline) induced a rapid
and robust fluid secretion in the isolated ducts. Consid-
ering the intense response observed, sympathetic stimu-
lation may have more functional significance than previ-
ously believed. As norepinephrine stimulates both α and
β-adrenergic receptors, the pharmacological background of
the observed secretory response was investigated. Stim-
ulation of α-adrenergic receptors with phenylephrine in
the presence of β-adrenergic blocker propranolol resulted
in a pronounced ductal fluid secretion similar to that
observed during application of norepinephrine. In contrast,
no detectable fluid secretion was observed by the activa-
tion of β-adrenergic receptors with isoproterenol in the
presence of α-adrenergic antagonist phentolamine. These
results are in accordance with a previously published study,
where high density of α-adrenergic receptors and very
weak presence of β-adrenergic receptors were found in
LG ducts by immunostaining.20 Our results strongly suggest
the involvement of the sympathetic nervous system in the
regulation of ductal fluid secretion. Decisive role of α-
adrenergic stimulation in the sympathetic neurotransmis-
sion was demonstrated because no β-adrenergic induced
fluid secretion could be observed. The α-adrenergic recep-
tor subtype present in the acinar epithelial cells of LG is the
α1D, not the more common α1A or α1B. Selective α1D receptor
blocker BMY-7378 could completely abolish phenylephrine-
induced ductal fluid secretion in our experiments, proving
the involvement of the same receptor subtype in the sympa-
thetic innervation of LG ducts. The intracellular mechanisms
underlying α1D-adrenergic receptor stimulation was found
to be more complex and less clearly clarified compared
to α1A and α1B subtypes.22 To elucidate the intracellular
mechanisms underlying α-adrenergic stimulated ductal fluid
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FIGURE 5. Effects of phenylephrine and carbachol on [Ca2+]i in cells of isolated mouse lacrimal gland ducts. Ducts were preincubated with
Ca2+-sensitive fluorescent dye FURA 2AM (5 μM) and then stimulated either with phenylephrine (10 μM) or with carbachol (100 μM). (A)
Representative recordings of the micro-fluorescence experiments: effect of phenylephrine (10 μM) on [Ca2+]i in lacrimal gland duct cells (left
curve). Carbachol (100 μM) was used as a positive control in these experiments (right curve) (F380/340: 380/340 nm fluorescence emission
ratio). (B) Maximum values of the 380/340 nm fluorescence emission ratios (Fmax(380/340): maximum value of the 380/340 nm fluorescence
emission ratio).
secretion, the role of NO/cGMP pathway was investigated.
Both eNOS inhibitor L-NAME and guanylyl cyclase inhibitor
ODQ reduced but not entirely blocked phenylephrine-
evoked ductal fluid secretion. These findings differed from
the results obtained by Hodges et al. in rat LG acinar cells
where application of either L-NAME or ODQ resulted in a
complete blockade of phenylephrine-induced protein secre-
tion.18 An additional and obviously NO/cGMP pathway-
independent mechanism was supposed in the background
of the observed partial blockade. Because α-adrenergic stim-
ulation is generally linked to Ca2+ signaling, the effect of
phenylephrine on [Ca2+]i and ductal fluid secretion was
investigated.23 Although phenylephrine stimulation resulted
in a small but statistically significant elevation of [Ca2+]i, no
statistically significant difference could be demonstrated in
the fluid secretion between the Ca2+-chelator BAPTA-AM-
treated and nontreated ducts.
To specify the role of the observed increase in
[Ca2+]i in the α-adrenergic stimulation-enhanced fluid secre-
tion, further series of experiments were performed. In
these experiments, Ca2+ signaling was excluded by co-
administration of intracellular Ca2+-chelator BAPTA-AM
either with L-NAME or ODQ. Under these circumstances,
complete blockade of phenylephrine-induced ductal fluid
secretion could be reached demonstrating the apparent role
of NO/cGMP pathway-independent Ca2+ signaling mecha-
nism.
Although the main intracellular event in the fluid secre-
tion evoked by phenylephrine is the activation of the
guanylyl-cyclase-cGMP pathway even though minor eleva-
tion of [Ca2+]i plays some role. Blockage of the cGMP path-
way alone markedly reduced but not completely abolished
fluid secretion, whereas in combination with depletion of
[Ca2+]i resulted in complete stoppage. On the other hand,
because the elevation of [Ca2+]i was small, distraction of Ca2+
itself did not result in significant reduction in fluid secre-
tion, although some tendency of lower secretory rates could
be noticed (without reaching the statistically significant
level).
In conclusion, our data strongly suggest the direct role of
α-adrenergic stimulation in LG ductal fluid secretion. Lack
of isoproterenol-induced fluid secretory response and the
similar secretory effects of norepinephrine and phenyle-
phrine suggest that the determining adrenergic pathway
is via α1D-adrenergic receptors in mouse LG ducts. Inhi-
bition of phenylephrine-induced ductal fluid secretion by
α1D-adrenergic receptor antagonist or by reduction of fluid
secretion by either eNOS or guanylyl cyclase inhibitors
suggest that α-adrenergic agonists use the NO/cGMP path-
way through α1D receptor stimulation to increase fluid
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secretion, but involvement of a NO/cGMP pathway-
independent Ca2+ signaling mechanism is also assumed.
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